#PRIYO CHITROSATHI NEWS💐
Kolkata, June 8, 2026 — CK Birla Hospitals, CMRI marked World Brain Tumour Day today with a press conference led by Dr Amitabha Chanda, Director of Neurosurgery, bringing together clinicians, and patients who had undergone brain tumour surgery at the hospital. The event examined how neurosurgical practice has changed over the past three decades and what those changes mean for patients who receive a brain tumour diagnosis today.
The press conference also addressed the broader direction of brain tumour treatment. Precision medicine, in which the genetic and molecular characteristics of a tumour are used to guide treatment selection, is moving from specialist centres into clinical practice more broadly.
Dr Amitabha Chanda, Director of Neurosurgery, CK Birla Hospitals, CMRI, said, "Brain tumour surgery has changed substantially in the past decade, and the change is most visible in outcomes. Imaging technology now allows us to map critical brain functions such as speech, movement, memory, vision before we enter the operating room. Neuronavigation systems guide the surgical approach in real time. Intraoperative monitoring alerts the team immediately if any critical pathway is at risk. Fluorescence-guided surgery helps distinguish tumour tissue from healthy tissue with a clarity that was not previously available. Awake craniotomy, where the patient remains conscious during specific stages of the procedure, allows us to monitor and preserve function while removing the maximum amount of tumour. Each of these has reduced the risk profile of procedures that would previously have been approached with considerable hesitation, or not attempted at all."
Adding a leadership perspective, Dr. Sombrata Roy, Unit Head, CK Birla Hospitals, CMRI, said, “On World Brain Tumour Day, our focus is not only on clinical excellence but also on awareness and empathy. Early consultation and timely diagnosis can truly change the course of treatment and recovery. The hospital emphasises into patient experience sharing sessions, where patients and caregivers share their journey of diagnosis, treatment, and recovery, highlighting the importance of early intervention and multidisciplinary care”.
Artificial intelligence is being applied to tumour characterisation, surgical planning, and outcome prediction in ways that are beginning to influence how individual cases are managed. Minimally invasive techniques now available, including endoscopic approaches that allow certain tumours to be accessed through the nasal passages without any external incision, have reduced recovery times and surgical trauma significantly.
World Brain Tumour Day draws attention to the gap between what is now clinically achievable and what patients and families know to expect when a diagnosis is made. Awareness of early warning signs, including persistent headaches, unexplained visual disturbances, seizures, memory changes, or progressive weakness, and timely neurological evaluation remain the factors that most directly determine what treatment options are available.
About CMRI
CK Birla Hospital, CMRI stands as a distinguished NABH accredited multi-specialty hospital established in 1969 in Kolkata. With 440 beds, CMRI is committed to delivering top-notch medical care to all segments of society. Team ENT that has been at the fore front of introducing state of art treatment options for ENT problems to Eastern India and are now partnering with the Neurosurgical, Maxillofacial, Plastic and Robotic surgery teams to enable removal of complex brain tumours through the nose and ear as also to provide scarless robotic thyroid surgery and complex reconstructive solutions to head and neck cancers.
About the CKA Birla Group
The CKA Birla Group, is an Indian multinational conglomerate with a multibillion dollar revenue. With over 35,000 employees, the group operates more than 50 manufacturing facilities across India and the world, with a presence in diverse sectors including technology, automotive, home and building and healthcare.
0 Comments